ID: ALA5267795

Max Phase: Preclinical

Molecular Formula: C18H13N3O3

Molecular Weight: 319.32

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1/C=c1\c(=O)[nH]n2c(=O)c3ccccc3nc12

Standard InChI:  InChI=1S/C18H13N3O3/c1-24-15-9-5-2-6-11(15)10-13-16-19-14-8-4-3-7-12(14)18(23)21(16)20-17(13)22/h2-10H,1H3,(H,20,22)/b13-10-

Standard InChI Key:  UMPOFBSFXHFDBV-RAXLEYEMSA-N

Associated Targets(Human)

PTGS2 Tclin COX-1/COX-2 (288 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.32Molecular Weight (Monoisotopic): 319.0957AlogP: 1.09#Rotatable Bonds: 2
Polar Surface Area: 76.46Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.65CX Basic pKa: 2.87CX LogP: 2.20CX LogD: 2.03
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.60Np Likeness Score: -0.80

References

1. Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K..  (2022)  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.,  13  (5.0): [PMID:35685617] [10.1039/d1md00280e]

Source